Complexo Hospitalario Universitario A Coruna — Clinical Trial Site

455 Registered trials

182 Currently recruiting

Organisation

Complexo Hospitalario Universitario A Coruna

Location

A Coruna, Spain

Identifier

ORG-100041242

Address

Lugar Jubias De Arriba 84, 15006, Spain

Departments

-
#034020 Oncología
#2001: Reumatología
#2307:servicio de neurología
#40045: Reumatologia e Immunologia
#40045: Servicio de Neurología
#40045:Reumatologia e Immunologia
#4211:Servicio Medicina Interna
#7016:Reumatologia e Immunologia
1202:Oncologia Médica
1503: Cirugía Plástica
2254:Reumatologia
2402: Reumatología
2402:Rheumatology
3010; Enfermedades Infecciosas
3013:Reumatología
34009: Oncologia Médica
3503: Cirujano Plástico Pediátrico
40806: Reumatologia e Immunologia
4206:Reumatologia
602: Reumatología
7001:Oncología Médica
7002: Medical Oncology
7005: Oncologia Médica
7006: Oncologia Médica
7506 Rheumatology
C.H.Universitario A Coruña_Heart failure unit
Cardiología
Cardiologia (Unidad de IC Avanzada y Trasplante Cardíaco)
Cardiology
Clinical and Translational Reumathology Unit
Complexo Hospitalario Universitario A Coruña
Department of Hematology
Department of Urology
Dermatology
Endocrinología
Endocrinology
Endocrinology and metabolism
Endocrinology and Nutrition
Endocrinology and Nutrition Service
Endocrinology Service
Endrocrinology
ES10008: Hematología
ESP009: Oncología Médica
ESP02-0: Oncologia Médica
Gynecology and Obstetrics
Haematology Service
Hematologia
Hematology
Hematology Department
Hemostasis and Thrombosis
infectious diseases
Internal Medicine
Internal medicine- Infectious Diseases
Lipidology
Maxilofacial
Medical Oncology
MEDICAL ONCOLOGY
Medical Oncology Department
Medical Oncology. Thoracic Tumors Unit
Medicina Interna
N/A
NA
Neonatology Department
Nephrology
Nephrology department, As Xubias 84, PC 15006. A Coruña, Spain
Neumology
Neurología
Neurology
Neurology / Stroke
Neurology Department
Oncologia
Oncología Médica
Oncologica
Oncology
Oncology department
Oncology Medicine
Oncology Service
Paediatric Cardiology
Pediatric Cardiology
Pediatric Surgery
Pediatrics
Pneumology
Pneumology service
Preventive medicine
Pulmonary
Research Facility
Reumathology
Reumatología
Reumatology
Rheumatologist
Rheumatology
Rheumatology Service
Serv. De Reumatología
Servicio de Cardiología
Servicio de Cardiología Pediàtrica
Servicio de Dermatología
Servicio de Endocrinología
Servicio de Endocrinología y Nutrición
Servicio de Enfermedades Infecciosas
Servicio de Hematología
Servicio de Medicina Interna
Servicio de Medicina Preventiva
Servicio de neumología
Servicio de Neurologia
Servicio de Neurología Pediátrica
Servicio de Oncología
Servicio de Oncología Médica
Servicio de Pediatría
Servicio de Reumatología
Servicio de Urologia
SERVICIO ONCOLOGÍA
Servicio Oncología Médica
Servico de Reumatologia
Thoracic Surgery
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Unidad de lesionados medulares
Urology

Clinical trials at this site (455)

Search interface

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides difficile Infection: The Re… Recruiting

2022-502972-22-00 Clostridioides difficile infection. 5 2024-10-31
A phase 3 trial comparing a therapeutic cancer vaccine OSE2101 to chemotherapy docetaxel in patients with metastatic Non-Small Cell Lung Can… Recruiting

2023-509340-10-00 Patients with HLA-A2 positive phenotype and metastatic 5 2024-10-29
A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc… Recruiting

2024-511319-91-00 Advanced non-small cell lung cancer with HER2 (ERBB2) m 5 2024-10-23
Beamion PANTUMOR-1: A study to test whether zongertinib helps people with advanced cancers with HER2 alterations Recruiting

2023-510429-14-00 HER2-mutated or overexpressed/amplified solid tumours 4 2024-10-22
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
Phase II Study to Assess the Efficacy of Niraparib Rechallenge after Surgery in Ovarian Cancer Patients with Oligometastatic Progression (Th… Recruiting

2023-508258-24-00 Ovarian cancer (OC) with oligometastatic progression (O 4 2024-09-12
A study comparing TAR-210 versus single agent treatment instilled directly into the bladder in people with bladder cancer with FGFR gene alt… Recruiting

2023-507684-19-00 FGFR+ Intermediate-risk Non-muscle Invasive Bladder Can 5 2024-07-24
Study of RMC-6291 and RMC-6236 With Other Anti-Cancer Agents in Patients With RAS G12C-Mutated NSCLC - Subprotocol A Recruiting

2023-509571-16-00 Lung Cancer 3 2024-07-17
A study of RMC-6236 in combination with pembrolizumab in participants with nonsmall cell lung cancer with certain mutations -Subprotocol B Recruiting

2023-509572-42-00 Lung Cancer 3 2024-07-17
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
Clinical trial of MK-2870 in combination with pembrolizumab in people who have had surgery to treat triple negative breast cancer Recruiting

2023-504962-52-00 Triple negative breast cancer. 5 2024-07-10
Beta-Blockers in Takotsubo Syndrome: A Randomized Clinical Trial Recruiting

2023-510213-25-01 Takotsubo Syndrome (TT) is an acute cardiac condition 6 2024-07-08
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism Recruiting

2024-511959-18-01 Acute Pulmonary Embolism 5 2024-07-01
A clinical study to test the effect of niraparib and immunotherapy, for patients with small cell lung cancer (SCLC) that is positive for SLF… Recruiting

2022-502092-33-00 Extensive-disease small cell lung cancer and high SLFN1 4 2024-05-31
A study of ASP3082 in adults with advanced solid tumors Recruiting

2022-501590-39-00 Solid Tumor 1 2024-05-22
A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Recruiting

2023-503631-18-01 Nervous system diseases 5 2024-05-20
Bevacizumab plus encorafenib-cetuximab in BRAF-V600E mutated metastatic colorectal cancer, a phase II study with a safety lead-in cohort, th… Recruiting

2023-509204-15-00 Metastatic colorectal cancer 4 2024-05-17
A trial to learn if volrustomig is safe and efficacious in women and young adults with locally advanced cervical cancer. Recruiting

2023-504374-38-00 Locally advanced cervical cancer 5 2024-04-12
A Global Pivotal Placebo-Controlled Study of LY3537982 in Combination with Pembrolizumab and LY3537982 in Combination with Pembrolizumab, Pe… Recruiting

2023-503412-33-00 Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small 5 2024-03-29
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
A clinical study to compare MK-2870 with pembrolizumab to pembrolizumab alone in people with lung cancer (MK-2870-007) Recruiting

2023-503376-24-00 Metastatic non-small cell lung cancer (NSCLC) 5 2024-03-20
A Master rollover study to provide continued access to, and assess, long term safety of the study drugs. Recruiting

2023-506330-73-00 Advanced (unresectable or metastatic) human epidermal g 5 2024-03-13
A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adul… Recruiting

2023-504863-17-00 1. Lupus Erythematosus, Cutaneous, Subacute 2. Chronic 5 2024-02-21
Alpelisib for the treatment of lymphatic malformations associated with a PIK3CA mutation Recruiting

2023-504146-60-00 lymphatic malformations associated with PIK3CA mutation 10 2024-02-07